Insider Trading - Duncan Barbara Gayle

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Duncan Barbara Gayle
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-09-15
Sale
2020-09-16
6:43 pm
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
10,000 $10 $100,000 34,271
(Direct)
View
2018-03-15
Sale
2018-03-19
6:42 pm
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
2,000 $28.11 $56,220 44,271
(Direct)
View
2018-01-26
Sale
2018-01-29
8:26 pm
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
4,000 $25 $100,000 46,271
(Direct)
View
2017-10-17
Purchase
2017-10-18
4:16 pm
Aevi Genomic Medicine Inc. GNMX Duncan Barbara Gayle
Director
59,524 $1.26 $75,000 70,115
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-07-01
Option Award
2021-07-02
5:00 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
379,788 $0 379,788
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:45 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-21
5:35 pm
N/A
2031-06-17
Atea Pharmaceuticals Inc. AVIR Duncan Barbara Gayle
Director
34,025 $0 34,025
(Direct)
View
2021-06-11
Option Award
2021-06-11
8:31 pm
N/A
2031-06-10
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-06-07
4:14 pm
N/A
2031-06-03
Fusion Pharmaceuticals Inc. FUSN Duncan Barbara Gayle
Director
17,000 $0 17,000
(Direct)
View
2021-05-17
Option Award
2021-05-18
8:57 pm
N/A
2031-05-16
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
1,750 $0 1,750
(Direct)
View
2020-10-30
Option Award
2020-11-03
4:56 pm
N/A
2030-10-29
Fusion Pharmaceuticals Inc. FUSN Duncan Barbara Gayle
Director
30,000 $0 30,000
(Direct)
View
2020-10-29
Option Award
2020-10-30
5:49 pm
N/A
2030-10-28
Atea Pharmaceuticals Inc. AVIR Duncan Barbara Gayle
Director
80,000 $0 80,000
(Direct)
View
2020-10-23
Disposition
2020-10-23
5:32 pm
N/A
N/A
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
59,502 $0 0
(Direct)
View
2020-09-15
Exercise
2020-09-16
6:43 pm
N/A
2026-05-09
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
10,000 $0 34,271
(Direct)
View
2020-09-15
Exercise
2020-09-16
6:43 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
10,000 $4.21 34,271
(Direct)
View
2020-09-14
Exercise
2020-09-15
4:30 pm
2020-03-05
2026-03-05
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
2,500 $0 52,962
(Direct)
View
2020-09-14
Exercise
2020-09-15
4:30 pm
N/A
N/A
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
2,500 $16.96 52,962
(Direct)
View
2020-08-17
Exercise
2020-08-20
4:15 pm
2020-03-05
2026-03-05
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
20,000 $0 50,462
(Direct)
View
2020-08-17
Exercise
2020-08-20
4:15 pm
N/A
N/A
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
20,000 $16.96 50,462
(Direct)
View
2020-08-12
Exercise
2020-08-14
4:33 pm
N/A
N/A
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
17,077 $12.93 30,462
(Direct)
View
2020-08-12
Exercise
2020-08-14
4:33 pm
2020-06-07
2026-06-07
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
17,077 $0 30,462
(Direct)
View
2020-06-26(A)
Option Award
2020-07-02
7:32 pm
N/A
2030-06-26
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
15,700 $0 15,700
(Direct)
View
2020-07-01
Option Award
2020-07-01
5:06 pm
2021-07-01
2030-07-01
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
144,000 $0 144,000
(Direct)
View
2020-06-26
Option Award
2020-06-29
7:30 pm
N/A
2030-06-26
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
13,550 $0 13,550
(Direct)
View
2020-06-18
Option Award
2020-06-22
5:19 pm
2021-06-18
2030-06-18
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
10,258 $0 19,925
(Direct)
View
2020-06-05
Option Award
2020-06-08
5:37 pm
N/A
2030-06-04
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
13,250 $0 13,250
(Direct)
View
2020-02-03
Disposition
2020-02-05
4:23 pm
N/A
2028-04-17
Aevi Genomic Medicine Inc. GNMX Duncan Barbara Gayle
Director
200,115 $0 0
(Direct)
View
2019-11-13
Option Award
2019-11-15
4:24 pm
N/A
2029-11-12
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
7,437 $0 7,437
(Direct)
View
2019-06-10(A)
Option Award
2019-08-01
5:00 pm
N/A
2029-06-09
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
5,813 $0 5,813
(Direct)
View
2019-07-02
Option Award
2019-07-03
5:00 pm
2020-07-02
2029-07-02
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
124,000 $0 124,000
(Direct)
View
2019-06-12
Option Award
2019-06-13
10:32 am
N/A
2029-06-12
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
15,700 $0 15,700
(Direct)
View
2019-06-07
Option Award
2019-06-11
4:31 pm
2020-06-07
2026-06-07
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
26,744 $0 26,744
(Direct)
View
2019-06-07
Option Award
2019-06-10
4:21 pm
N/A
2029-06-06
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
5,813 $0 5,813
(Direct)
View
2019-03-05
Option Award
2019-03-07
6:40 pm
2020-03-05
2026-03-05
IMMUNOMEDICS INC IMMU Duncan Barbara Gayle
Director
22,500 $0 22,500
(Direct)
View
2018-06-14(A)
Option Award
2018-07-18
4:17 pm
N/A
2028-04-17
Aevi Genomic Medicine Inc. GNMX Duncan Barbara Gayle
Director
50,000 $0 50,000
(Direct)
View
2018-06-22
Option Award
2018-06-26
5:00 pm
2019-06-22
2028-06-22
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
158,233 $0 158,233
(Direct)
View
2018-06-19
Option Award
2018-06-21
5:15 pm
N/A
2028-06-19
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
13,550 $0 13,550
(Direct)
View
2018-06-14
Option Award
2018-06-18
4:16 pm
N/A
2028-04-17
Aevi Genomic Medicine Inc. GNMX Duncan Barbara Gayle
Director
50,000 $0 50,000
(Direct)
View
2018-06-07
Option Award
2018-06-08
5:41 pm
N/A
2028-06-06
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
5,813 $0 5,813
(Direct)
View
2018-03-15
Exercise
2018-03-19
6:42 pm
N/A
2026-05-09
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
2,000 $0 44,271
(Direct)
View
2018-03-15
Exercise
2018-03-19
6:42 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
2,000 $4.21 44,271
(Direct)
View
2018-01-26
Exercise
2018-01-29
8:26 pm
N/A
2026-05-09
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
4,000 $4.21 46,271
(Direct)
View
2017-06-22
Option Award
2017-08-10
9:27 pm
2018-06-22
2027-06-22
Aevi Genomic Medicine Inc. GNMX Duncan Barbara Gayle
Director
20,000 $0 20,000
(Direct)
View
2017-07-03
Option Award
2017-07-03
5:03 pm
2018-07-03
2027-07-03
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
228,765 $0 228,765
(Direct)
View
2017-06-14
Option Award
2017-06-15
5:51 pm
N/A
2027-06-13
Ovid Therapeutics Inc. OVID Duncan Barbara Gayle
Director
11,627 $0 11,627
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next